Clinical Trial Update: Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Switch versus guideline-directed interventions to relieve aromatase inhibitor-related side effects in breast cancer p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Switch

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Breast Cancer, Adjuvant Treatment | Phase 2 | Status: RECRUITING